G. Sen

Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy

Şahin Bedir, G. Sen, Hamza Abbasov, Murad Guliyev et autres

tr (code pays fourni par la source)

Association between obesity and outcomes of first-line CDK4/6 inhibitor therapy in metastatic breast cancer: a multicenter real-world study

Murat Günaltılı, Murad Guliyev, Zeliha Birsin, Emir Çerme et autres

tr, kh, ag (code pays fourni par la source)

Clinical Analysis of Multiple Primary Malignant Tumors: A Single-Center Experience

Şahin Bedir, Nilay Şengül Samancı, Emir Çelik, Kerem Oruç et autres

tr (code pays fourni par la source)

The impact of low HER2 expression on clinicopathological features and clinical outcomes in patients with metastatic gastric cancer

Murad Guliyev, Shamkhal Safarov, Murat Günaltılı, Mehmet Cem Fidan et autres

tr, kh, ag (code pays fourni par la source)

Prognostic Significance of Inflammatory and Nutritional Biomarkers in Patients with Metastatic Gastric Cancer

Murad Guliyev, Özkan Alan, Shamkhal Safarov, G. Sen et autres

tr (code pays fourni par la source)

Effects of immune related adverse events and corticosteroids on the outcome of patients treated with immune checkpoint inhibitors

G. Sen, Nihan Şentürk Öztaş, Ezgi Değerli, Shamkhal Safarov et autres

tr (code pays fourni par la source)

The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors

Murad Guliyev, Ali Kaan Güren, Emre Özge, Rumeysa Çolak et autres

tr, kh (code pays fourni par la source)

Obesity Is an Independent Prognostic Factor That Reduced Pathological Complete Response in Operable Breast Cancer Patients

Murad Guliyev, Özkan Alan, Murat Günaltılı, Shamkhal Safarov et autres

tr (code pays fourni par la source)

Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer

G. Sen, Nihan Şentürk Öztaş, Ezgi Değerli, Murad Guliyev et autres

tr (code pays fourni par la source)

The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer

G. Sen, Esra Aydın, Murad Guliyev, Nihan Şentürk Öztaş et autres

tr (code pays fourni par la source)

Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors

G. Sen, Nihan Şentürk Öztaş, Ezgi Değerli, Murad Guliyev et autres

tr (code pays fourni par la source)

The Impact of Age on Treatment Responses in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

G. Sen, Hande Turna